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Abstract 
We investigated the effect of preconditioning on ischemia-reperfusion injury in the rat 
bladder.  Rat abdominal aorta was clamped with a small clip to induce 
ischemia-reperfusion injury in the bladder.  Twelve-week-old male SD rats were 
divided into three groups; sham-operated control (Cont), 30 minutes ischemia-60 
minutes reperfusion (IR) and three times of 5 minutes ischemia and then 30 minutes 
ischemia-60 minutes reperfusion (PC) groups.  The bladder functions were estimated 
by cystometric and functional studies.  Contractile response curves to increasing 
concentrations of carbachol were constructed in the absence and presence of various 
concentrations of subtype selective muscarinic antagonists, i.e.  atropine 
(non-selective) pirenzepine (M1 selective), methoctramine (M2 selective), and 4-DAMP 
(M1/M3 selective).  We also measured tissue levels of malonaldehyde (MDA) and 
examined possible histological changes in these rat’s bladders.  Preconditioning 
partially prevented the reduction of bladder dysfunction induced by 
ischemia-reperfusion.  Estimation of the pA2 values for atropine, pirenzepine, 
methoctramine, and 4-DAMP indicate that the carbachol-induced contractile response in 
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bladder dome is mediated through the M3 receptor subtype in all groups.  The MDA 
concentration in the IR group was significantly larger than that of the control group, and 
preconditioning significantly reduced MDA production in the bladder.  In histological 
studies, the ischemia-reperfusion with or without preconditioning caused infiltration of 
leukocytes and rupture of microcirculation in the regions of submucosa and smooth 
muscle without a corresponding sloughing of mucosal cells.  Our data indicate that 
preconditioning has a beneficial effect on ischemia-reperfusion injury in the rat bladder. 
 
 
 
Key words: urinary bladder, preconditioning, ischemia-reperfusion, muscarinic 
receptors
 4 
Introduction 
  The functions of the urinary bladder include urine storage and subsequent micturition. 
The urinary bladder requires an adequate supply of oxygen and nutrients via the 
circulation system in order to maintain homeostasis and proper function (Parekh et al., 
2001).  Both clinical and experimental evidences of ischemia and subsequent 
reperfusion injury have been reported in many tissues, including such as kidney, liver, 
stomach, and heart (Rauen et al., 1999).  Ischemia and the following reperfusion of the 
bladder are observed in age-related disorders, urinary retention, atherosclerosis, 
vasospasm, embolization, and thrombosis (Parekh et al., 2001).  Bladder 
overdistention occurs in patients with acute urinary retention secondary to bladder outlet 
obstruction (Carpenter et al., 1983).  Overdistension, as a physiological or pathological 
stress, has been shown to result in contractile and metabolic dysfunction of bladder (Lee 
et al., 2000).  Prolonged overdistension can result in injury to the neural pathways 
responsible for micturition (Tammela et al., 1990), reduce bladder elasticity, alter the 
biochemical and neuronal responsiveness of the bladder (Carpenter et al., 1983), and 
subsequently lead to micturition problems.  We have reported that, after overdistension, 
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catheterization/decompression induce reperfusion injury in the bladder and that reactive 
oxygen species are one of the main contributing factors in this injury (Saito et al., 2001).  
Ischemia-reperfusion injury may cause dysfunction of the urinary bladder, which results 
in instability and impairment of detrusor contractility during urination (Greenland et al., 
2001).  Experimentally we have reported that ischemia and subsequent reperfusion 
significantly damage the bladder function measured by organ bath studies and 
histological studies (Saito et al., 1998; Saito et al., 2002; Saito and Miyagawa, 1999). 
  Ischemic preconditioning (PC) is defined as brief, non-injurious ischemia-reperfusion 
(IR) periods that render a tissue more resistant to the harmful effects of a subsequent 
prolonged period of ischemia through endogenous cellular protective mechanisms.  Its 
protective effect from IR injury was first shown by Murry and coworkers on the canine 
heart (Murry et al., 1986).  Subsequently, benefits of PC in many other tissues, such as 
central nervous system, skeletal muscle, kidney, liver, lung, and mesenteric endothelium 
have been shown from many groups.  PC may play an important role in the 
development of bladder dysfunction caused by acute/chronic urinary retention and by 
ischemia-reperfusion.  To our knowledge, however, limited information is available 
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about the effect of PC in the bladder dysfunction.  Lorenzi et al. reported the effect of 
preconditioning in guinea-pig in vitro (Lorenzi et al., 2003).  They suggest that in vitro 
short periods of transient ischemia may be able to protect the guinea-pig bladder from 
the impairment associate with longer periods of ischemia-reperfusion.  However, 
identified mechanisms of ischemia-reperfusion include altered Ca2+ homeostasis, free 
radical formation, mitochondrial dysfunction, protease activation, altered gene 
expression, and inflammation (Neumar, 2000).  From these points, it is important to 
perform in vivo study to understand effect of PC on the bladder.  In order to clarify the 
effect of PC on ischemia-reperfusion in the bladder, we investigated the role of PC on 
ischemia-reperfusion injury in the rat bladder in vivo.
 7 
Mater ials and Methods 
Animal model 
  All animal experiments were performed in accordance with the guidelines set by the 
Tottori University Committee for Animal Experimentation.  Male Sprague Dawley rats, 
12 weeks old and weighing 380-420 g (SLC, Shizuoka, Japan), were divided into 3 
groups; sham-operated control (Cont), 30 minutes ischemia-60 minutes reperfusion (IR) 
and three times of five minutes ischemia and then 30 minutes ischemia-60 minutes 
reperfusion (PC) group (In each group, n= 6-8).  Our protocol is shown in figure 1. 
The ischemic condition was conducted according to previous reports with minor 
modifications (Saito et al., 1999).  Briefly, under anesthesia with ethyl carbamate 
(1mg/kg, hypodermoclysis), the abdominal aorta just above the bifurcation of the aorta 
was clamped with a small clip (Sugita standard aneurysm clip, holding force 145 g, 
Mizuho Ikakogyo, Tokyo, Japan).  The PC condition was initiated that before 30 
minutes ischemia, aorta was clamped three times at the same site of aortic occlusion for 
5 minutes followed by 5 minutes of reperfusion after each ischemic episode.  In our 
previous study, the clamping the abdominal artery decreased blood flow of urinary 
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bladder to 5-10 % of the preclamping levels (Saito et al., 1999). 
 
Cystometr ic studies.  
  The cystometric studies were performed according to methods used in our previous 
report (Saito et al., 2007).  Cystometry was performed under anesthesia with ethyl 
carbamate (1.0 mg/kg, subcutaneously).  In short, after the experimental periods, each 
rat’s abdomen was opened using a lower midline incision and the bladder was exposed, 
and cystometry was carried out with a 24 G catheter inserted into the apex of the 
bladder dome for the purpose of recording pressure and in order to fill the bladder with 
physiological saline (0.9 % NaCl).  External bladder filling was carried out using an 
infusion pump (5200, TOP, Tokyo) at a constant rate of 0.4 ml/min until micturition was 
detected.  A cystometry catheter was connected to an external pressure transducer 
(P2310, Gould, Eastlake, OH) for the measurement of intravesical pressure.  
Intravesical pressure was recorded on the personal computer (Macintosh G3, Apple 
Computer, Cupertino, CA) via a bridge amplifier (ML112, AD Instruments, Castle Hill, 
Australia) and multiports controller (Power Lab/16sp, AD Instruments).  The 
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following parameters were evaluated: probability of urination, bladder capacity, 
maximum detrusor pressure during voiding (Pdet), and residual urine volume.  The 
Pdet was defined as instantaneous pressure minus the post-contraction resting pressure 
according to our previous reports.  Probability of urination was defined as (total 
number of animals – the number of animals with overdistention) / (total number of 
animals).  In each animal, approximately 5-6 voiding cycles were recorded and then 
the means of the voiding cycles were calculated. 
  
Tissue preparation and measurement of contractile force in the bladder. 
  Functional studies were conducted according to methods used in our previous reports 
(Saito et al., 2007).  The rat bladder dome was immediately removed and separated 
from the bladder base at the level of the ureteral orifices.  Razor blades were used to 
obtain uniform longitudinal strips of the posterior wall of the bladder dome (1.5 x 5 
mm).  One end was fixed to a hook in the bottom of the muscle chamber, and the other 
end was fastened to a force displacement transducer.  Muscle strips were mounted in 
organ baths (25 ml) containing Krebs-Henseleit solution, and bubbled with 5% CO2 and 
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95% O2 (37℃).  One hook was suspended from a transducer  (type 45196A, San-ei 
Instruments, Tokyo, Japan), and the lower hook was fixed to a plastic support leg 
attached to a micrometer (Mitutoyo, Tokyo, Japan).  Each strip was equilibrated 
unstretched for 30 minutes.  A load of 1.0 g was applied to each strip by micrometer 
adjustment, and the load was readjusted to this level 30 minutes later.  Changes in the 
tone of the strips were measured isometrically by means of force transducers, and the 
data were recorded on a personal computer (Macintosh G3, Apple Computer, Cupertino, 
CA) with the use of Chart v 3.6.9 software and a Power Lab/16sp data acquisition 
system (AD Instruments, Castle Hill, Australia).  Cumulative concentration-response 
curves to carbachol and KCl (100 mM) were constructed.  These studies demonstrated 
that the resting stress at which bladder dome developed maximum contractile forces was 
in the range of 2.5-3.0 gm./mm2.  Carbachol-induced contractile responses were 
measured cumulatively in the presence or absence of various concentrations of 
muscarinic antagonists: pirenzepine (PRZ; M1 selective), methoctramine (MTR; M2 
selective), 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP; M1/M3 
selective), and atropine (ATR; nonselective).  Antagonists were added 60 minutes prior 
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to the administration of carbachol.  After completion of a concentration-response curve, 
the tissue was washed until base-line force returned to the resting level, equilibrated for 
60 minutes, and then the next consecutive concentration-response curve was 
constructed.  
 
Measurement of malonaldehyde (MDA) in the bladder  
 In order to investigate lipid peroxidation of the bladder during ischemia-reperfusion, 
malonaldehyde (MDA), a marker of lipid peroxidation, concentrations were measured 
in the experimental rat bladders.  The tissues were chopped into small pieces and the 
pieces were then homogenized in 9 volumes of PBS buffer in 5 mM BHT with five 10 
second bursts using the Multi-beads Shocker○R  (YASUIKIKI, Osaka, Japan) with the 
speed set at 1800 rpm.  Then the MDA concentrations in the bladder were measured by 
colorimetric assay according to the manufacturer’s instructions (BIOXYTECH 
MDA-586TM kits, OXIS International, Portland, OR).  The absorbance was measured 
at 586 nm.  The values were estimated based on the amount of protein in the tissue.  
Protein was determined using a commercial kit (Protein Assay Rapid Kitwako, Wako 
 12 
Pure Chemical, Osaka, Japan). 
 
 Histological examination of the rat bladder.   
  After each bladder was transected at the level of the ureteral orifice, the bladder dome 
was immediately fixed with 10% formalin.  After fixation, the tissues were embedded 
in paraffin.  Five micron-thick tissue sections were cut from these paraffin blocks.  
All of the bladder specimens were stained using Hematoxylin and Eosin (H&E) staining. 
Each section was viewed under a light microscope at a magnification of x40-400.  
 
 Data analysis.  
  Contractile data were calculated as grams of active force per cross sectional area in 
square millimeters.  The cross-sectional area was calculated using the following 
equation:  
             cross-sectional area = weight / (length x 1.05), 
where 1.05 is the assumed density of the muscle (Saito and Miyagawa, 1999; Saito et al., 
2007).   The dose ratio was obtained from the ratio of EC50 values (the concentration 
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of agonist that produces half-maximal contractile responses) for carbachol in the 
presence or absence of an antagonist.   
pA2 values were obtained from Schild plots (Arunlakshana and Schild, 1959).  Schild 
plots were constructed by plotting the log of (dose ratio –1) against the log of the molar 
concentration of antagonist.  EC50 values were calculated as geometric means, whereas 
Emax
 
 values were calculated as arithmetic means.  A statistical comparison of 
differences between groups was performed using analysis of variance and Fisher’s 
multiple comparison tests.  P< 0.05 was regarded as the level of significance.   
Drug and Chemicals. 
  Ethyl carbamate was purchased from Wako Pure Chemical Co. (Osaka, Japan).  
Carbachol, pirenzepine, methoctramine, 4-DAMP, and atropine were purchased from 
Sigma Chemical Co. (St. Louis, Mo., USA).  All other chemicals used were of reagent 
grade. 
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Result 
Cystometr ic studies.  
  Table1 shows the data of cystometrogram in the experimental rats.  In the IR group, 
the probability of urination was decreased, and in the PC group probability of urination 
was slightly greater than that in the IR group.  The maximum detrusor pressure (Pdet) 
in the IR group was significantly lower than that of the control group.  The Pdet in the 
PC group did not differ significantly from that in the both IR and Cont groups.  In the 
bladder capacity, although the IR rats treated with PC tended to be improved, the 
differences in two groups were not significant statistically.  The residual urine volume 
in both the IR and PC rats was markedly greater than that of the controls.  In 
cystometric studies, we note that the PC group was closer to the control group in terms 
of the probability of urination, Pdet, and the bladder capacity than IR group. 
 
Contractile force in the bladder.  
  The data obtained by functional studies of the experimental animals are shown in 
Table 2 and 3.  Concentration-response curves to carbachol were shown in Fig. 2.  
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The Emax values of carbachol in the IR rats were markedly smaller than those of the 
control rats.  The Emax values were improved by treatment with PC.  Contractile 
responses to 100 mM KCl showed in the same manner as Emax
ATR≧4-DAMP＞MTR＞PRZ 
 values of carbachol in 
each group.  The pA2 values for a series of muscarinic antagonists were similar in all 
groups and the rank order of the values is as follows;  
 
Biochemical analysis.   
  The tissue concentrations of MDA are also shown in Table 4. The MDA 
concentrations in the bladder of the IR group were significantly higher than those of the 
control group.  MDA concentrations were significantly decreased in PC rats compared 
to IR and control groups.   
 
Histological examination.   
  Fig. 3 shows H&E staining of the rat bladder.  In control rats, high levels of normal 
viability cells were observed.  In the IR group, histological damage was observed, with 
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infiltration of leukocytes and ruptures of microcirculation in the regions of submucosa 
and smooth muscle without a corresponding sloughing of mucosal cells.  In the PC 
group, ruptures of microcirculation and leukocyte infiltration in the bladder were also 
observed.  Significant protective effects of the PC were not observed in these 
histological examinations.  
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Discussion 
  In the present study, we investigated the effect of PC on ischemia-reperfusion injury 
in the rat bladder.  Our previous and present data indicated that ischemia-reperfusion 
produced significant damages of bladder function estimated by cystometric and 
functional studies.  Treatment with three times of 5 minutes PC improved this injury.  
We also demonstrated that one of these preventive mechanisms was to reduce the 
production of free radicals produced by ischemia-reperfusion in the bladder. 
In the past, much attention has focused on the effects of preconditioning on vital organs, 
such as the heart and brain (Pong, 2004), but little has been reported about the effects of 
PC in the bladder.  Lorenzi and coworkers reported that in vitro short periods of 
transient ischemia may be able to protect the guinea-pig bladder from the 
impairment associated with longer periods of ischemia and reperfusion, which might 
happen in obstructed micturition, and that the phenomenon affects mainly the 
intrinsic nerves, which are more susceptible to ischemic damage than the smooth 
muscle (Lorenzi et al., 2003).  Furthermore, Yu et al reported that hypoxic PC 
minimizes oxidative injury induced by overdistension/emptying in the rat bladder (Yu et 
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al., 2003).  In their report, they concluded that hypoxia-reoxygeneration and 
ischemia-reperfusion lead to the generation of reactive oxygen species (ROS), the 
induction of Bcl-2 protein expression by hypoxic PC appears to reflect the bladder’s 
up-regulation of the endogeneous antioxidant-induced defense system.  The effects 
enable to survive a subsequent ischemia-reperfusion stress by reducing an oxidative 
insult and preserving bladder nerve activity and contractile function.  
  As we suspected that ROS played an important role to prevent ischemia-reperfusion 
injury in the bladder, we measured the concentrations of MDA, a marker of lipid 
peroxidation, in the experimental bladder.  In the present study, the MDA 
concentrations in the bladder were significantly increased in the IR group.  Treatment 
with PC significantly decreased MDA production by ischemia-reperfusion, and 
interestingly, the MDA concentration in the PC group was significantly lower than that 
of the Cont group.  Gurucum and associates recently reported a preventive effect of 
remote preconditioning in spinal cord ischemia-reperfusion injury (Gurcun et al., 2006).  
In their study, both direct PC and remote PC caused by occlusion of left renal artery 
have a preventive effect on spinal cord ischemia-reperfusion injury, and the plasma 
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MDA concentrations after ischemia-reperfusion with PC were significantly smaller than 
pre-ischemia levels.  These data suggest that at least PC has an effect to reduce ROS 
production in the ischemia-reperfusion organs.  As increases in lipid peroxidation can 
produce nerve and smooth muscle membrane damage, PC may associate with defensive 
mechanism that reduce lipid peroxidation.   
  It is known that PC activates a cellular survival program that requires the integration 
of several processes including opening of surface KATP channels, regulation of fatty acid 
metabolism, ROS production, regulation of the mitochondrial permeability transition 
and opening of K+ channels in the mitochondrial inner membrane (Hanley and Daut, 
2005).  In the functional studies, contractile responses to carbachol and KCl were 
significantly decreased by ischemia-reperfusion, which was partially prevented by 
induction of PC.  These observed decrease in contractile responses might indicate that 
ischemia-reperfusion injures or alters the muscarinic receptors on the bladder smooth 
muscle membrane and their second messenger system.  Since we thought a possibility 
of alterations of these systems, we calculated the pA2 values and their slopes for a series 
of muscarinic antagonists in order to investigate affinity of receptor.  In this study, 
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there were no significant differences of the pA2 values and slopes between any groups 
in all muscarinic antagonists.  These data indicated that alterations of contractile 
responses of bladder smooth muscles were due to quantitative rather than qualitative 
changes of muscarinic receptors and their second messenger system.   
  In this study, we demonstrated the effect of PC during ischemia-reperfusion in the 
bladder, and we also demonstrated that one of these mechanisms is to reduce production 
of ROS in the bladder.  However, roles of opening of surface KATP channels, regulation 
of fatty acid metabolism, nitric oxide production, regulation of the mitochondrial 
permeability transition and opening of K+ channels in the mitochondrial inner 
membrane are not clear.  In order to understand the precise mechanisms of PC, it is 
important to investigate these effects on the bladder.  However, the detailed mechanism 
of this preventive effect remains unclear, and warrants further study. 
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Conclusion 
Ischemia-reperfusion injury significantly reduces the contractile force of the bladder 
smooth muscle, which is partially prevented by PC.  However, the changes of the 
receptor characteristics concerned with the contractile responses to stimulus from 
muscarinic receptors were not observed.  Our data indicate that PC has a beneficial 
effect on ischemia-reperfusion injury in the rat bladder, and one of the mechanisms is to 
reduce ROS production in the bladder. 
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Figure legends 
 
Fig 1. Protocol in this study. 
 
Fig. 2. Contractile responses of rat bladder smooth muscle to carbachol. 
Contractile data were calculated as grams of active force per cross sectional area in 
square millimeters.   
 
Fig 3. Typical H&E staining in the rat bladder. 
Ruptures of microcirculation (short arrows) and leukocyte infiltration (long arrows) in 
the regions of submucosa and smooth muscle of the bladder were observed in IR and 
PC Groups (X 200).   
 
Table 1.  cystometrogram data in the exper imental rats 
 
Group     Probability        Pdet         Bladder capacity     Residual urine 
          of  urination     (cm H2
Cont  100  %   42.8 ± 2.3  0.70 ± 0.18  0.034 ± 0.010 
O)          (ml)             (ml)      
 IR  53.8  %  34.0 ± 2.1*  0.53 ± 0.10  0.233 ± 0.057*  
 PC  61.5  %  35.4 ± 2.9  0.59 ± 0.14  0.430 ± 0.105* 
Data are shown as mean ± S.E.M. of five to nine separated determinations in each 
group.  Pdet means maximum contraction pressure of the detrusor.  *:significantly 
different from the Cont group. 
  
Table 2. Functional studies in the experimental rats 
 
Group    Emax/cross-sectional area    EC50         KCl/ cross-sectional area     
             (g/mm2)            (?10 –6 M)        (g/mm2)                
Cont  2.25 ? 0.16   4.3 ? 0.5  1.50 ? 0.15 
IR  1.61 ? 0.10*          3.1 ? 0.3*  1.04 ? 0.67* 
PC  1.87 ? 0.17          2.0 ? 0.2**  1.09 ? 0.90*        
Data are shown as mean ?S.E.M. of six to eight separated determinations in each 
group.  Emax and ED50 values are for carbachol.  KCl means contractile force to 100 m 
mol/l KCL.  *: significantly different from the Cont group.  **: significantly different 
from the other groups.  
 
Table 3.  pA2 values and Slopes of Schlid Plots for  muscar inic antagonists in the exper imental rat bladder  
 
           ATR   PRZ   MTR    4-DAMP       
Group      pA2    Slope  pA2    Slope  pA2    Slope  pA2    Slope 
 (± S.E.M.)  (± S.E.M.)   (± S.E.M.)  (± S.E.M.) 
Cont    9.57  0.950 ± 0.055 7.29  0.924 ± 0.096  7.94 0.533 ± 0.087  9.39 0.95 ± 0.055 
    (9.44 - 9.77)       (7.23 – 7.37)    (7.81 – 8.12)     (9.28 – 9.54) 
IR     9.35  0.977 ± 0.095  7.46  0.917 ± 0.062  7.98  0.568 ± 0.1  9.70 0.977 ± 0.095 
        (9.26 – 9.47)     (7.37 – 7.57)     (7.77 – 8.40)     (9.62 – 9.81) 
PC    10.0*  1.101 ± 0.099  7.22 1.028 ± 0.026  7.82  0.541 ± 0.108  9.44  1.101 ± 0.099  
        (9.88 – 10.18)*    ( 7.16 – 7.29)    (7.64 – 8.14)    (9.36 – 9.54)  
Data are shown as mean ±S.E.M. of five to nine separated determinations in each group.  *:significantly different from the other 
group.  ATR: atropine; PRZ: pirenzepine; MTR: methoctoramine 
 
 
Table 4.  MDA concentrations in experimental rat bladders 
  
 Group               MDA concentrations (n mol/mg protein) 
 Cont                   3.87 ? 0.16 
IR                    4.72 ? 0.29* 
   PC                    3.05 ? 0.24**            
Data are shown as mean ?S.E.M. of six to eight separated determinations in each group.  
*: significantly different from the Cont group.  **:significantly different from the other 
groups. 
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